| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 2.49e-04 | 120 | 51 | 4 | GO:0004222 | |
| GeneOntologyMolecularFunction | cell-cell adhesion mediator activity | 5.09e-04 | 61 | 51 | 3 | GO:0098632 | |
| GeneOntologyMolecularFunction | calcium ion binding | 5.76e-04 | 749 | 51 | 8 | GO:0005509 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 7.64e-04 | 430 | 51 | 6 | GO:0004175 | |
| GeneOntologyMolecularFunction | cell adhesion mediator activity | 9.68e-04 | 76 | 51 | 3 | GO:0098631 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.35e-03 | 188 | 51 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | metallopeptidase activity | 1.69e-03 | 200 | 51 | 4 | GO:0008237 | |
| GeneOntologyBiologicalProcess | dermatan sulfate catabolic process | 5.50e-05 | 5 | 49 | 2 | GO:0030209 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 8.01e-05 | 187 | 49 | 5 | GO:0007156 | |
| GeneOntologyCellularComponent | cell surface | CD93 NID2 PLA2R1 CLSTN3 DSG2 TLR2 ADAM30 SLAMF7 DCBLD2 GPRC5B ALPP | 5.01e-05 | 1111 | 50 | 11 | GO:0009986 |
| GeneOntologyCellularComponent | vacuolar lumen | 6.57e-05 | 178 | 50 | 5 | GO:0005775 | |
| GeneOntologyCellularComponent | lysosomal lumen | 8.86e-05 | 98 | 50 | 4 | GO:0043202 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.51e-04 | 530 | 50 | 7 | GO:0062023 | |
| GeneOntologyCellularComponent | extracellular matrix | 8.97e-04 | 656 | 50 | 7 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 9.13e-04 | 658 | 50 | 7 | GO:0030312 | |
| Domain | PD866254 | 9.42e-07 | 8 | 49 | 3 | PD866254 | |
| Domain | Beta_defensin | 2.52e-05 | 22 | 49 | 3 | IPR025933 | |
| Domain | Defensin_beta_2 | 2.52e-05 | 22 | 49 | 3 | PF13841 | |
| Domain | Cadherin | 2.18e-04 | 113 | 49 | 4 | PF00028 | |
| Domain | CADHERIN_1 | 2.18e-04 | 113 | 49 | 4 | PS00232 | |
| Domain | CADHERIN_2 | 2.26e-04 | 114 | 49 | 4 | PS50268 | |
| Domain | - | 2.26e-04 | 114 | 49 | 4 | 2.60.40.60 | |
| Domain | CA | 2.33e-04 | 115 | 49 | 4 | SM00112 | |
| Domain | Cadherin-like | 2.41e-04 | 116 | 49 | 4 | IPR015919 | |
| Domain | Cadherin | 2.58e-04 | 118 | 49 | 4 | IPR002126 | |
| Domain | Disintegrin_CS | 7.90e-04 | 16 | 49 | 2 | IPR018358 | |
| Domain | ADAM_CR | 1.00e-03 | 18 | 49 | 2 | PF08516 | |
| Domain | - | 1.24e-03 | 20 | 49 | 2 | 4.10.70.10 | |
| Domain | DISIN | 1.37e-03 | 21 | 49 | 2 | SM00050 | |
| Domain | Disintegrin | 1.37e-03 | 21 | 49 | 2 | PF00200 | |
| Domain | TRYPSIN_SER | 1.70e-03 | 90 | 49 | 3 | IPR033116 | |
| Domain | cEGF | 2.11e-03 | 26 | 49 | 2 | IPR026823 | |
| Domain | cEGF | 2.11e-03 | 26 | 49 | 2 | PF12662 | |
| Domain | ADAM_Cys-rich | 2.27e-03 | 27 | 49 | 2 | IPR006586 | |
| Domain | ACR | 2.27e-03 | 27 | 49 | 2 | SM00608 | |
| Domain | TRYPSIN_HIS | 2.50e-03 | 103 | 49 | 3 | IPR018114 | |
| Domain | TRYPSIN_SER | 2.71e-03 | 106 | 49 | 3 | PS00135 | |
| Domain | TRYPSIN_HIS | 2.78e-03 | 107 | 49 | 3 | PS00134 | |
| Domain | Cadherin_CS | 2.93e-03 | 109 | 49 | 3 | IPR020894 | |
| Domain | Peptidase_S1A | 3.24e-03 | 113 | 49 | 3 | IPR001314 | |
| Domain | EGF_3 | 3.32e-03 | 235 | 49 | 4 | PS50026 | |
| Domain | TRYPSIN_DOM | 3.41e-03 | 115 | 49 | 3 | PS50240 | |
| Domain | Tryp_SPc | 3.58e-03 | 117 | 49 | 3 | SM00020 | |
| Domain | - | 3.80e-03 | 35 | 49 | 2 | 3.20.20.80 | |
| Domain | Trypsin | 3.93e-03 | 121 | 49 | 3 | PF00089 | |
| Domain | Trypsin_dom | 3.93e-03 | 121 | 49 | 3 | IPR001254 | |
| Domain | EGF-like_dom | 4.08e-03 | 249 | 49 | 4 | IPR000742 | |
| Domain | Peptidase_S1_PA | 4.12e-03 | 123 | 49 | 3 | IPR009003 | |
| Domain | Glyco_hydro_catalytic_dom | 4.46e-03 | 38 | 49 | 2 | IPR013781 | |
| Domain | Peptidase_M12B_N | 4.70e-03 | 39 | 49 | 2 | IPR002870 | |
| Domain | Pep_M12B_propep | 4.70e-03 | 39 | 49 | 2 | PF01562 | |
| Domain | IG | 4.80e-03 | 421 | 49 | 5 | SM00409 | |
| Domain | Ig_sub | 4.80e-03 | 421 | 49 | 5 | IPR003599 | |
| Domain | EGF-like_CS | 4.82e-03 | 261 | 49 | 4 | IPR013032 | |
| Domain | DISINTEGRIN_1 | 4.94e-03 | 40 | 49 | 2 | PS00427 | |
| Domain | ADAM_MEPRO | 4.94e-03 | 40 | 49 | 2 | PS50215 | |
| Domain | DISINTEGRIN_2 | 4.94e-03 | 40 | 49 | 2 | PS50214 | |
| Domain | Reprolysin | 4.94e-03 | 40 | 49 | 2 | PF01421 | |
| Domain | Peptidase_M12B | 4.94e-03 | 40 | 49 | 2 | IPR001590 | |
| Domain | EGF_2 | 5.09e-03 | 265 | 49 | 4 | PS01186 | |
| Domain | CYSTEINE_SWITCH | 5.18e-03 | 41 | 49 | 2 | PS00546 | |
| Domain | Disintegrin_dom | 5.18e-03 | 41 | 49 | 2 | IPR001762 | |
| Domain | Pept_M10_metallopeptidase | 5.69e-03 | 43 | 49 | 2 | IPR001818 | |
| Domain | Growth_fac_rcpt_ | 7.95e-03 | 156 | 49 | 3 | IPR009030 | |
| Domain | Glycoside_hydrolase_SF | 8.53e-03 | 53 | 49 | 2 | IPR017853 | |
| Domain | IG_LIKE | 9.06e-03 | 491 | 49 | 5 | PS50835 | |
| Domain | Ig-like_dom | 9.99e-03 | 503 | 49 | 5 | IPR007110 | |
| Pathway | REACTOME_SYNTHESIS_OF_PA | 4.23e-06 | 41 | 38 | 4 | MM14583 | |
| Pathway | REACTOME_BETA_DEFENSINS | 5.14e-06 | 43 | 38 | 4 | M565 | |
| Pathway | REACTOME_DEFENSINS | 1.20e-05 | 53 | 38 | 4 | M557 | |
| Pathway | REACTOME_BETA_DEFENSINS | 2.00e-05 | 20 | 38 | 3 | MM14567 | |
| Pathway | REACTOME_DEFENSINS | 7.71e-05 | 31 | 38 | 3 | MM14568 | |
| Pathway | REACTOME_ANTIMICROBIAL_PEPTIDES | 1.35e-04 | 98 | 38 | 4 | M27627 | |
| Pathway | REACTOME_SYNTHESIS_OF_PA | 1.54e-04 | 39 | 38 | 3 | M653 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | 2.95e-04 | 120 | 38 | 4 | MM14585 | |
| Pathway | REACTOME_CS_DS_DEGRADATION | 5.42e-04 | 13 | 38 | 2 | MM14805 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.05e-04 | 258 | 38 | 5 | MM14572 | |
| Pathway | REACTOME_CS_DS_DEGRADATION | 6.31e-04 | 14 | 38 | 2 | M651 | |
| Pathway | REACTOME_KERATAN_SULFATE_DEGRADATION | 7.27e-04 | 15 | 38 | 2 | M691 | |
| Pathway | REACTOME_KERATAN_SULFATE_DEGRADATION | 7.27e-04 | 15 | 38 | 2 | MM14799 | |
| Pathway | REACTOME_ANTIMICROBIAL_PEPTIDES | 8.73e-04 | 70 | 38 | 3 | MM15332 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | 9.38e-04 | 17 | 38 | 2 | MM14580 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_DEGRADATION | 9.38e-04 | 17 | 38 | 2 | M39832 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PI | 9.38e-04 | 17 | 38 | 2 | M626 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | 1.05e-03 | 18 | 38 | 2 | M700 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | 1.18e-03 | 19 | 38 | 2 | MM14581 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | 1.18e-03 | 620 | 38 | 7 | MM15193 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.19e-03 | 300 | 38 | 5 | M610 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_DEGRADATION | 1.44e-03 | 21 | 38 | 2 | M3624 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | 1.58e-03 | 22 | 38 | 2 | M703 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | 1.73e-03 | 23 | 38 | 2 | MM14577 | |
| Pathway | REACTOME_PHOSPHOLIPID_METABOLISM | 1.85e-03 | 196 | 38 | 4 | MM14591 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | 2.38e-03 | 27 | 38 | 2 | M643 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PE | 2.56e-03 | 28 | 38 | 2 | MM14578 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | 2.56e-03 | 28 | 38 | 2 | MM14575 | |
| Pathway | REACTOME_ACYL_CHAIN_REMODELLING_OF_PE | 2.74e-03 | 29 | 38 | 2 | M702 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 3.54e-03 | 114 | 38 | 3 | MM14571 | |
| Pathway | KEGG_LYSOSOME | 4.18e-03 | 121 | 38 | 3 | M11266 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 4.21e-03 | 36 | 38 | 2 | M690 | |
| Pathway | REACTOME_KERATAN_SULFATE_KERATIN_METABOLISM | 4.21e-03 | 36 | 38 | 2 | MM14632 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 4.37e-03 | 995 | 38 | 8 | MM14661 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 4.38e-03 | 123 | 38 | 3 | MM14623 | |
| Pathway | REACTOME_GLYCOSAMINOGLYCAN_METABOLISM | 4.68e-03 | 126 | 38 | 3 | M695 | |
| Pathway | REACTOME_GLYCEROPHOSPHOLIPID_BIOSYNTHESIS | 4.89e-03 | 128 | 38 | 3 | M706 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM | 5.43e-03 | 41 | 38 | 2 | M27257 | |
| Pathway | REACTOME_IMMUNOREGULATORY_INTERACTIONS_BETWEEN_A_LYMPHOID_AND_A_NON_LYMPHOID_CELL | 5.67e-03 | 135 | 38 | 3 | MM14781 | |
| Pubmed | RETN DRAXIN PI16 PLA2G12A CXCL17 DEFB123 TMEM161B ADAM30 ADAM33 SLAMF7 HSD17B11 | 1.50e-07 | 985 | 51 | 11 | 12975309 | |
| Pubmed | 2.05e-07 | 430 | 51 | 8 | 16303743 | ||
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 3.95e-07 | 101 | 51 | 5 | 20551380 | |
| Pubmed | The structure of the human betaII-tryptase tetramer: fo(u)r better or worse. | 2.11e-06 | 2 | 51 | 2 | 10500112 | |
| Pubmed | Characterization of a tryptase mRNA expressed in the human basophil cell line KU812. | 2.11e-06 | 2 | 51 | 2 | 8434231 | |
| Pubmed | Cloning and characterization of a second complementary DNA for human tryptase. | 2.11e-06 | 2 | 51 | 2 | 2203827 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10898108 | ||
| Pubmed | Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. | 2.11e-06 | 2 | 51 | 2 | 9521329 | |
| Pubmed | Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. | 2.11e-06 | 2 | 51 | 2 | 2187193 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 15567416 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 10391906 | ||
| Pubmed | The human mast cell tryptase tetramer: a fascinating riddle solved by structure. | 2.11e-06 | 2 | 51 | 2 | 10708850 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 17449330 | ||
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 2170400 | ||
| Pubmed | Desmoglein 2 is a substrate of kallikrein 7 in pancreatic cancer. | 2.11e-06 | 2 | 51 | 2 | 19091121 | |
| Pubmed | 2.11e-06 | 2 | 51 | 2 | 31337736 | ||
| Pubmed | A mouse knockout library for secreted and transmembrane proteins. | 4.74e-06 | 460 | 51 | 7 | 20562862 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 16877769 | ||
| Pubmed | Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3. | 6.32e-06 | 3 | 51 | 2 | 9920877 | |
| Pubmed | 6.32e-06 | 3 | 51 | 2 | 19748655 | ||
| Pubmed | Identification, characterization, and evolution of a primate beta-defensin gene cluster. | 1.26e-05 | 4 | 51 | 2 | 15772680 | |
| Pubmed | Pcdh19 mediates olfactory sensory neuron coalescence during postnatal stages and regeneration. | 1.26e-05 | 4 | 51 | 2 | 37965156 | |
| Pubmed | Development and maturation of invariant NKT cells in the presence of lysosomal engulfment. | 2.10e-05 | 5 | 51 | 2 | 19637231 | |
| Pubmed | 2.10e-05 | 5 | 51 | 2 | 10843716 | ||
| Pubmed | Discovery of five conserved beta -defensin gene clusters using a computational search strategy. | 2.23e-05 | 37 | 51 | 3 | 11854508 | |
| Pubmed | 3.15e-05 | 6 | 51 | 2 | 29051512 | ||
| Pubmed | CD300 heterocomplexes, a new and family-restricted mechanism for myeloid cell signaling regulation. | 3.15e-05 | 6 | 51 | 2 | 20959446 | |
| Pubmed | New developments in the genetics and activation of mast cell proteases. | 3.15e-05 | 6 | 51 | 2 | 12217407 | |
| Pubmed | Activation of invariant NKT cells by the helminth parasite schistosoma mansoni. | 3.15e-05 | 6 | 51 | 2 | 16456008 | |
| Pubmed | Signal peptide prediction based on analysis of experimentally verified cleavage sites. | 4.29e-05 | 264 | 51 | 5 | 15340161 | |
| Pubmed | The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions. | 4.41e-05 | 7 | 51 | 2 | 19359216 | |
| Pubmed | The CD300 molecules regulate monocyte and dendritic cell functions. | 4.41e-05 | 7 | 51 | 2 | 19592130 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 4.71e-05 | 135 | 51 | 4 | 28675934 | |
| Pubmed | 6.39e-05 | 146 | 51 | 4 | 27068509 | ||
| Pubmed | CMRF-35-like molecule-1, a novel mouse myeloid receptor, can inhibit osteoclast formation. | 1.63e-04 | 13 | 51 | 2 | 14662855 | |
| Pubmed | 1.90e-04 | 14 | 51 | 2 | 27551807 | ||
| Pubmed | Polymorphisms in innate immunity genes and risk of childhood leukemia. | 2.40e-04 | 206 | 51 | 4 | 20438785 | |
| Pubmed | Risk of meningioma and common variation in genes related to innate immunity. | 2.45e-04 | 207 | 51 | 4 | 20406964 | |
| Pubmed | Common variation in genes related to innate immunity and risk of adult glioma. | 2.49e-04 | 208 | 51 | 4 | 19423540 | |
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 3.29e-04 | 91 | 51 | 3 | 28558017 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | 3.36e-04 | 1201 | 51 | 8 | 35696571 | |
| Pubmed | A single cell transcriptional atlas of early synovial joint development. | 3.94e-04 | 20 | 51 | 2 | 32580935 | |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 3.97e-04 | 97 | 51 | 3 | 27559042 | |
| Pubmed | The DNA sequence and comparative analysis of human chromosome 20. | 9.52e-04 | 517 | 51 | 5 | 11780052 | |
| Pubmed | 1.22e-03 | 35 | 51 | 2 | 25977363 | ||
| Pubmed | 1.22e-03 | 35 | 51 | 2 | 16033865 | ||
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | 1.26e-03 | 824 | 51 | 6 | 20237496 | |
| Pubmed | DLK1 is a novel regulator of bone mass that mediates estrogen deficiency-induced bone loss in mice. | 1.28e-03 | 145 | 51 | 3 | 21308776 | |
| Pubmed | 1.38e-03 | 329 | 51 | 4 | 17474147 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 1.45e-03 | 569 | 51 | 5 | 30639242 | |
| Interaction | TMEM67 interactions | 1.67e-05 | 129 | 50 | 5 | int:TMEM67 | |
| Cytoband | 20q11.1 | 1.21e-05 | 5 | 51 | 2 | 20q11.1 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 8.27e-05 | 394 | 34 | 6 | 471 | |
| GeneFamily | Defensins, beta | 9.31e-05 | 47 | 34 | 3 | 503 | |
| GeneFamily | Non-clustered protocadherins | 2.24e-04 | 12 | 34 | 2 | 21 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 1.17e-03 | 27 | 34 | 2 | 47 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 3.51e-03 | 163 | 34 | 3 | 590 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 3.00e-05 | 91 | 51 | 4 | M40180 | |
| Coexpression | GSE3039_CD4_TCELL_VS_B1_BCELL_DN | 4.35e-05 | 200 | 51 | 5 | M6468 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 4.35e-05 | 35 | 51 | 3 | MM17054 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.10e-11 | 196 | 51 | 8 | 23e22dfb9f9aec17b83574295f889e75f46ded50 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.82e-09 | 198 | 51 | 7 | af682919a874d60f579e854c274dc47063015ea9 | |
| ToppCell | Caecum-(6)_Macrophage|Caecum / shred on region, Cell_type, and subtype | 3.03e-09 | 200 | 51 | 7 | 2ce3930645c3daf6be578f7881e57a58df61e75c | |
| ToppCell | Caecum-Macrophage|Caecum / Region, Cell class and subclass | 3.03e-09 | 200 | 51 | 7 | d83209559187a4419df2508ecc5eb9f7d72fced3 | |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.10e-08 | 186 | 51 | 6 | cc94e0c5d1665d2ea2bb871ad79d8e1ec2249fb5 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD1c+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 9.40e-08 | 195 | 51 | 6 | cd4d61a463e0e87b711e08ceedee5bef5d735e64 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.98e-08 | 197 | 51 | 6 | d568354aff89ac84dd06360f19100ef578a041ed | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|Mesenchymal_cells / Lineage and Cell class | 9.98e-08 | 197 | 51 | 6 | cb321836980e7b4efbb9284c6af7ccd34079d2be | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-07 | 198 | 51 | 6 | 96236fa22545f6f4ff3aa8dc002963db8a3468ce | |
| ToppCell | Caecum-(6)_Macrophage-(61)_LYVE1_Macrophage|Caecum / shred on region, Cell_type, and subtype | 1.03e-07 | 198 | 51 | 6 | e684c3934c163aef4d284b69435832d2c9614f2a | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Caecum / Region, Cell class and subclass | 1.03e-07 | 198 | 51 | 6 | a92c0cacb775aca6bbb302bd9e22c081a112a44d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-07 | 198 | 51 | 6 | 9e0fdd63069d17430cdc25bf4ffc762afd5e1728 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-Plasma_B-Plasma_B|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-07 | 198 | 51 | 6 | 7eb521af938c2609a85d27e2aa7d4317ad6e1e44 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-07 | 199 | 51 | 6 | c684530d4d8073337379c2a24e5e54297fb13691 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.06e-07 | 199 | 51 | 6 | 41d240d44bd6cc301a7879cacee104c874b4ba2c | |
| ToppCell | Sigmoid-(4)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 1.09e-07 | 200 | 51 | 6 | 7f3920a0434d5199c6c8f0b3064a305bb0d87b60 | |
| ToppCell | Sigmoid-Monocyte-Monocyte|Sigmoid / Region, Cell class and subclass | 1.09e-07 | 200 | 51 | 6 | 010ca36970cb8894bdbca08779c0ecf56be22fc9 | |
| ToppCell | Sigmoid-Monocyte|Sigmoid / Region, Cell class and subclass | 1.09e-07 | 200 | 51 | 6 | c41bd6ec0f2262fce5cadb37a400d487e6662f49 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-07 | 200 | 51 | 6 | c325dc52e4bf3829a35905b956784ca3e9191926 | |
| ToppCell | Sigmoid-(4)_Monocyte-(40)_Monocyte|Sigmoid / shred on region, Cell_type, and subtype | 1.09e-07 | 200 | 51 | 6 | 576c0a1098e6a934448705de3673ef798fcf1b26 | |
| ToppCell | (60)_Macrophage|World / shred on Cell_type and subtype | 1.23e-07 | 204 | 51 | 6 | 06d0cb306f1ad0014d81f8228868938e48c2bcf3 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_DC-DC-tDC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.53e-06 | 171 | 51 | 5 | b327fb7813a3cdae06c8a4f8a0c256e9a20132f6 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_DCN|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.76e-06 | 176 | 51 | 5 | 08f94b78b27feeb113dbfadbfa7fe34d08b2809b | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.91e-06 | 179 | 51 | 5 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | ICU-NoSEP-Myeloid-tDC|ICU-NoSEP / Disease, Lineage and Cell Type | 1.96e-06 | 180 | 51 | 5 | be665e801512f6aaf6b3ecb26153bbdeb24619ac | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.02e-06 | 181 | 51 | 5 | 79102845baee5af583eec24e9f91dfec46ab7de3 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-Macrophages|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.13e-06 | 183 | 51 | 5 | 92d5a61b57851090eba558f19e2a7010043eff81 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-Monocytes|normal_Lymph_Node / Location, Cell class and cell subclass | 2.18e-06 | 184 | 51 | 5 | 3cec28ff076fa53d034428de2bb1a237e0c1568c | |
| ToppCell | wk_08-11-Hematologic-Myeloid-DC3|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.18e-06 | 184 | 51 | 5 | 7d9294e5a55964903feda135e5bea0338824ed83 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c5-WDR74|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.24e-06 | 185 | 51 | 5 | 68edb1bb03ed221d49e583123ca4de14252d7bc5 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-06 | 186 | 51 | 5 | 07d94d5d1c2fe7bb909a07ca81058a0eabc65c60 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-cDC2|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-06 | 188 | 51 | 5 | c7c2cf1aa328e735073d6031e44b5dbd55beae6d | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.43e-06 | 188 | 51 | 5 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-myeloid|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.49e-06 | 189 | 51 | 5 | 2aebea7a6c2f83112d7c504b742f2c04b92e459a | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Mesenchymal-mesenchymal_stem_cell|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-06 | 189 | 51 | 5 | dde037322c8caec0c04c5be1c1b59a167824ad9f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.56e-06 | 190 | 51 | 5 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-06 | 191 | 51 | 5 | 0b296404ebad0aadb75737f8c0462ec6934fc8bb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.62e-06 | 191 | 51 | 5 | 9f0d956e9a14b1cd2c20a52639c6b22c349b377e | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-06 | 191 | 51 | 5 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.62e-06 | 191 | 51 | 5 | 1e668d67bc254ea15518e2c7a029a61087609b7a | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Myeloid-cDC2|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-06 | 192 | 51 | 5 | 90274b85f3d612b6a6d435860cd6d049ddeb1d96 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.69e-06 | 192 | 51 | 5 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_dendritic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.69e-06 | 192 | 51 | 5 | e24a8856ef01ccf69a5e968bd409f9b84befa91e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.76e-06 | 193 | 51 | 5 | 45205ad1ef12aabf33059a7ff922a3bb86994c2f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.76e-06 | 193 | 51 | 5 | 1beca3d3b34082b7d9112fbd094bee8019921ca0 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.76e-06 | 193 | 51 | 5 | 2ebb950476767f330241b0077ced22e55e124359 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.76e-06 | 193 | 51 | 5 | 52f5b0fbb8ca706206c65e7edbb1ddbd380aebae | |
| ToppCell | 390C-Myeloid-Monocyte-CD14+_Monocyte|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.76e-06 | 193 | 51 | 5 | a50ee6110ea272d9d9f41d48bb5d43711cc00a32 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c3-CD14-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.76e-06 | 193 | 51 | 5 | 00c9c2945d2bdaa128e054cf3c59df86a279b659 | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class | 2.83e-06 | 194 | 51 | 5 | c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9 | |
| ToppCell | 21-Trachea-Immune-Hematopoietic,_Macrophage|Trachea / Age, Tissue, Lineage and Cell class | 2.83e-06 | 194 | 51 | 5 | 3c4ac5f91b10802990b84db3406f5e71f8ee8b74 | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 2.90e-06 | 195 | 51 | 5 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | MS-granulo1-|MS / Condition, Cell_class and T cell subcluster | 2.90e-06 | 195 | 51 | 5 | eeaa2ecbcfbfb203c77261367b43ce55e786b312 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.90e-06 | 195 | 51 | 5 | febe746099964b9ea9e75f2efc72c962c01f0421 | |
| ToppCell | MS-granulo1|MS / Condition, Cell_class and T cell subcluster | 2.90e-06 | 195 | 51 | 5 | 29688f55a6cdefbff4e818c20cb89473fbc16a59 | |
| ToppCell | 3'-Adult-LargeIntestine-Hematopoietic-Myeloid-Monocytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-06 | 195 | 51 | 5 | aa3914e277918299dc7d2995c0c72288462ad43d | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-06 | 195 | 51 | 5 | 9168267a799bbd4111b1227754ab8173ac1a4714 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.90e-06 | 195 | 51 | 5 | 0ec1b572bbb92b6da3440139366a4c1743b1ad92 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.90e-06 | 195 | 51 | 5 | 391d8e00dd5f988baa6dbda8414d3c020679ea2f | |
| ToppCell | -Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.90e-06 | 195 | 51 | 5 | e5b0afbea85575851cf9eb50a9ac42c67bbf3d7c | |
| ToppCell | 15-Trachea-Mesenchymal|Trachea / Age, Tissue, Lineage and Cell class | 2.98e-06 | 196 | 51 | 5 | 7e178c76285e61c721c38d7a995ebf89dc428f9f | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Dendritic_cell-DC_1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.98e-06 | 196 | 51 | 5 | b71d711be5609115b00a57700885aca608920896 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-06 | 196 | 51 | 5 | 82fad623212d986a7fca3496faf3f8c8f5b83a11 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-DC2|lymph-node_spleen / Manually curated celltypes from each tissue | 2.98e-06 | 196 | 51 | 5 | 9666b5380e2b2a3c3b56a8c769817a1df8820ed6 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-06 | 196 | 51 | 5 | c2bbb48c4aa979b03cb6f4ce9f351f492977c992 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-DC3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.98e-06 | 196 | 51 | 5 | 20808c2ce010e4fcda092ecce94487f0afff733b | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-06 | 196 | 51 | 5 | 64c2abc0087bf2ae547932377f3662e3be1cc63e | |
| ToppCell | Control-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 2.98e-06 | 196 | 51 | 5 | 1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5 | |
| ToppCell | (7)_MNP-(7)_Monocyte|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.98e-06 | 196 | 51 | 5 | 4c2ea16352ba3482c02c03866460e0d975f9fc99 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-06 | 196 | 51 | 5 | 85e5046f774537684e1443c0fc147d562b7068d0 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.98e-06 | 196 | 51 | 5 | a44a648bf209ce037bfc7b3adfcb220aab60728c | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 2.98e-06 | 196 | 51 | 5 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.05e-06 | 197 | 51 | 5 | 0dd71e399f253787fa546a7e90c5373180b89ffd | |
| ToppCell | IIH-granulo1-|IIH / Condition, Cell_class and T cell subcluster | 3.05e-06 | 197 | 51 | 5 | 51be6d5652b17c70f3a33f244efc3b728ec56f5b | |
| ToppCell | (6)_Macrophage|World / shred on Cell_type and subtype | 3.05e-06 | 197 | 51 | 5 | 010b275d4da4a896175ad7fbaa96d1dc11a0b744 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.05e-06 | 197 | 51 | 5 | b212ff28ca2d1fea4140f186ab90941bdca21249 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.05e-06 | 197 | 51 | 5 | 71786e9432e2d649f5d86f639abb25e7102deb67 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-Monocytes|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-06 | 197 | 51 | 5 | d9d58c2fe40d9b5b9031fb7a71525a535927effe | |
| ToppCell | wk_15-18-Hematologic-Myeloid-S100A12-lo_cla._mono.|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.05e-06 | 197 | 51 | 5 | 5bf4d964a9ee82002d3bc9ba1f020902eb96de7a | |
| ToppCell | IIH-granulo1|IIH / Condition, Cell_class and T cell subcluster | 3.05e-06 | 197 | 51 | 5 | 39637e8b726bc58c0a6885c49713111f97aff881 | |
| ToppCell | (7)_MNP|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 3.05e-06 | 197 | 51 | 5 | 6790346736946984cc80d67668523ba70ab0b380 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue | 3.13e-06 | 198 | 51 | 5 | 2541f1095ed91e6789cb888cf39a208b8107726a | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c2-CCL3L1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.13e-06 | 198 | 51 | 5 | 7b61f427ed5ca8ad563e5f112fba950a24c9d956 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.13e-06 | 198 | 51 | 5 | 691a2f1779225e5519155460eeb6a2aac5f67a92 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 3.13e-06 | 198 | 51 | 5 | 934dacb67d71faa2f8732c39d7f8e64b0ee75396 | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 3.13e-06 | 198 | 51 | 5 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.13e-06 | 198 | 51 | 5 | 94e2567f057b2c455a9656b121321a28e7cb1d2b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.13e-06 | 198 | 51 | 5 | f3a12a7e23bb4ff6e82fee675dbc090d99587f69 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.13e-06 | 198 | 51 | 5 | aed0476248e9637897eefb1623ec4035f2dacd82 | |
| ToppCell | (4)_Monocyte|World / shred on Cell_type and subtype | 3.13e-06 | 198 | 51 | 5 | 56f9ebf902fe81c590696ba4c88028deaf346841 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.13e-06 | 198 | 51 | 5 | e115eea04012e9e492e923ed080e1723c38d14fd | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-AT1/AT2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.13e-06 | 198 | 51 | 5 | 33d1e0b6f57663544bee0ffdde83a65da764d44c | |
| ToppCell | Severe_COVID-19-Epithelial-AT1/AT2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 3.13e-06 | 198 | 51 | 5 | 43e33d28d9de5033bd00d39be953542a225236ed | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.13e-06 | 198 | 51 | 5 | 4961a3e9b953679648586afed04869ff36b81820 | |
| ToppCell | 10x5'-Liver-Myeloid_Monocytic|Liver / Manually curated celltypes from each tissue | 3.13e-06 | 198 | 51 | 5 | d0925948bf667545fb0b343e2fc80f7379e433e3 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.13e-06 | 198 | 51 | 5 | de21168c9c05873938cc65e82cce40ffd8e55df1 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.13e-06 | 198 | 51 | 5 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 3.21e-06 | 199 | 51 | 5 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.21e-06 | 199 | 51 | 5 | fde2b65afde69f402f1b7b056eaa266e9fd5b227 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.21e-06 | 199 | 51 | 5 | c4fc638a8dad3a9b77634e8912a9326c8a2f11f5 | |
| Drug | pimaradiene | 1.73e-06 | 11 | 51 | 3 | CID000440909 | |
| Drug | thymidine glycol monophosphate | 1.47e-05 | 3 | 51 | 2 | CID000165415 | |
| Disease | tryptase beta-2 measurement | 9.26e-05 | 9 | 48 | 2 | EFO_0008306 | |
| Disease | Liver Cirrhosis, Experimental | 2.40e-04 | 774 | 48 | 7 | C0023893 | |
| Disease | urticaria | 4.83e-04 | 20 | 48 | 2 | EFO_0005531 | |
| Disease | rhinitis (is_implicated_in) | 1.09e-03 | 30 | 48 | 2 | DOID:4483 (is_implicated_in) | |
| Disease | end stage renal disease (is_marker_for) | 2.56e-03 | 46 | 48 | 2 | DOID:783 (is_marker_for) | |
| Disease | basophil measurement | 4.32e-03 | 60 | 48 | 2 | EFO_0803539 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SFLMLLLPLLLLLVA | 6 | Q6UXB8 | |
| MLLITLFLLLPLSML | 6 | Q14264 | |
| MTLLLLPLLLASLLA | 1 | Q9BQT9 | |
| LVVLLKLPLLLSMLG | 176 | Q496F6 | |
| MATSMGLLLLLLLLL | 1 | Q9NPY3 | |
| TFLLAMLLSVLLPLL | 701 | Q9BZ11 | |
| MKFLLDILLLLPLLI | 1 | Q8NBQ5 | |
| LLVLLELPLLLSMLG | 186 | Q08708 | |
| ALMILAFLLLLLVPL | 616 | Q14126 | |
| MESLLLPVLLLLAIL | 1 | Q8TAB3 | |
| MALLSRPALTLLLLL | 1 | Q9BZM1 | |
| MKTLLLLLLVLLELG | 1 | P14091 | |
| MKPLLLAISLSLIAA | 1 | Q5VSP4 | |
| RLLLPSMLLALLLLL | 36 | Q08174 | |
| MPRLSLLLPLLLLLL | 1 | Q8WX77 | |
| MARSLLLPLQILLLS | 1 | P49862 | |
| MKTLQSTLLLLLLVP | 1 | P20774 | |
| LVLLLTLPLHLMALL | 11 | Q6UX53 | |
| LLKMLSFPLLLLAVT | 521 | O60774 | |
| MKLLLLALPMLVLLP | 1 | Q96PH6 | |
| MLLRALLLLLLLSPL | 16 | Q2VWP7 | |
| ALLLLLPATMFHLLL | 21 | O76062 | |
| LLLMLILLVRLPFIK | 71 | Q9NZH0 | |
| VLSSLPVLLLLPLLM | 11 | Q14112 | |
| MLLLLLLLGLRLQLS | 6 | P05187 | |
| CRLLLLLVPTMLLKS | 11 | Q9UKF2 | |
| LSLLGLLVMRNLLKP | 716 | Q9NQ11 | |
| MLFLVLLLPLELSLA | 11 | Q8NBI3 | |
| MSRELAPLLLLLLSI | 1 | Q13609 | |
| QTVLLLLPLLLMLFS | 1076 | Q8IZS8 | |
| LKLAALGSLLVLMVL | 16 | Q8NDZ4 | |
| MLGTLTPLSSLLLLL | 1 | P25067 | |
| KTLLDGILLPFMLLS | 206 | Q6NUI2 | |
| LLRKPVLTAMGLLAL | 381 | P35475 | |
| LLSLRILLLMKPSVL | 1221 | Q92538 | |
| SMPLFLLLLLVLLLL | 46 | Q96PD2 | |
| MKVLISSLLLLLPLM | 1 | Q6UXB2 | |
| MKLLLLTLTVLLLLS | 1 | Q8N688 | |
| MKLLLLLLTVTLLLA | 1 | Q5J5C9 | |
| PPMLLALLLATLLAA | 11 | P07686 | |
| MLNLLLLALPVLASR | 1 | Q15661 | |
| MLNLLLLALPVLASR | 1 | P20231 | |
| MSLLLPPLALLLLLA | 1 | Q8WWX9 | |
| PLVMLLHTTLLLKTL | 381 | Q8NDZ6 | |
| MKALLALPLLLLLST | 1 | P55083 | |
| MLLSPSLLLLLLLGA | 1 | Q13018 | |
| LTLPALSLPMKLVSL | 236 | Q2M1Z3 | |
| MVLLCLLLVPLLLSL | 226 | Q9NQ25 | |
| MLHVLASLPLLLLLV | 1 | A2RUT3 | |
| MKALCLLLLPVLGLL | 1 | Q9HD89 | |
| TLPDASLLPMLLVLK | 491 | O60603 | |
| LDLLALKPMSIISLL | 496 | Q6PIF6 |